Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-033654
Filing Date
2023-06-02
Accepted
2023-06-02 16:04:15
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4250
  Complete submission text file 0001209191-23-033654.txt   5712
Mailing Address 1001 SANTERRE DRIVE GRAND PRAIRIE TX 75050
Business Address
AUERBACH MARK (Reporting) CIK: 0001018007 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 23988607

Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

EIN.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations